期刊文献+

p-硝基苯甲磺酰吡咯烷的制备 被引量:4

Preparation of 1-(4-Nitrophenyl Methanesulfonyl) Pyrrolidine
下载PDF
导出
摘要 以氯苄为原料,经4步反应制得p-硝基苯甲磺酰吡咯烷.氯苄用发烟硝硫混酸硝化得p-硝基氯苄,产率为52%.p-硝基氯苄与亚硫酸钠反应得p-硝基苯甲磺酸钠,产率为96%.p-硝基苯甲磺酸钠用五氯化磷氯化得到p-硝基苯甲磺酰氯,产率为78%.p-硝基苯甲磺酰氯用吡咯烷氨解后得到目标产物,产率为98%.对各步反应的工艺进行了改进,提高了产率. 1-(4-Nitrophenyl methanesulfonyl) pyrrolidine (Ⅴ) was prepared by four-step reactions, starting from benzyl chloride (Ⅰ). p-Nitro benzyl chloride(Ⅱ)was prepared by the nitration of Ⅰwith fuming nitric acid-fuming sulfuric acid, with a yield of 52%. Sodium p-nitro benzyl sulfonate (Ⅲ)was prepared by the sulfonation of Ⅱ with Na_2SO_3, with a yield of 96%. p-Nitrophenyl methanesulfonyl chloride(Ⅳ), was obtained by chlorination of Ⅲ with PCl_5, with a yield of 78%. Aminolysis of Ⅳ with pyrrolidine gave the title compound Ⅴ, with a yield of 98%. The procedure was improved and total yield was increased.
出处 《北京理工大学学报》 EI CAS CSCD 北大核心 2004年第6期552-554,共3页 Transactions of Beijing Institute of Technology
关键词 制备 p-硝基苯甲磺酰吡咯烷 氯苄 preparation 1-(4-nitrophenyl methanesulfonyl) pyrrolidine benzyl chloride
  • 相关文献

参考文献6

  • 1Glaxo Group Limited. An indole derivative[P]. UK P: GB 2162522A, 1986.
  • 2Dykhanov N N, Egupova L M. p-Nitrobenzylchloride[J]. Chemical Abstracts, 1966, 65:7082b.
  • 3Fernardez-Forner D. New aniline derivatives as intermediates in synthesis of 5-HT1B/1D receptor agonists[J]. Research Disclosure, 1998,412:1088.
  • 4Wyrick S D,Hall I H, Dubey A. Structure-activity studies on antihyperlipide N-benzoylsulfamates, N-benzylsulfamates and benzylsulfonamides[J]. J Pharm Sci, 1984,73:374-377.
  • 5Bristol-Myers Squibb Company. Indolylalkyl deriva-tives of pyrimidinylpiperazine for treating vascular headache[P]. USP:5300506, 1994.
  • 6何进,刘皋林.阿莫曲普坦对偏头痛的治疗作用[J].世界临床药物,2003,24(3):136-140. 被引量:6

二级参考文献16

  • 1吴金华,王鹏.曲坦类化合物的合成研究[J].化工中间体,2006,2(3):28-30. 被引量:3
  • 2王尊元,王钟瑾,王国强.对氨基苯甲磺酰吡咯烷的合成[J].齐鲁药事,2007,26(2):106-107. 被引量:3
  • 3Pascual J;Falk RM;Piessens F.Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study[J],2000(06).
  • 4Dahlof C;Tfelt-Hansen P;Massiou H.Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine[J],2001(10).
  • 5Pascual J;Falk R;Docekal R;etal.Tolerability and efficacy of almotriptan in the long-term treatment of migraine,2001(04).
  • 6Spierings EL;Gomez-Mancilla B;Grosz DE.Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind,randomized, parallel-group, optimum-dose comparison,2001(06).
  • 7Ferrari MD;Roon KI;Lipton FIB.Oral triptans (serotonin 5-HT(1B/1 D) agonists) in acute migraine treatment: a meta-analysis of 53 trials,2001(9294).
  • 8Fleishaker JC;Ryan KK;Jansat JM.Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans[J],2001(05).
  • 9Gras J;Llenas J;Jansat JM.Almotriptan,a new anti-migraine agent:a review,2002(03).
  • 10Cabarrocas X;Esbri R;Peris F.Long-term efficacy and safety of oral almotriptan:interim analysis of a 1-year open study,2001(01).

共引文献6

同被引文献45

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部